Patient data from acute myeloid leukemia specimens
English
Scatterplot Serial List Genetics Data
数据描述
This dataset contains clinical and genomic data from patients with acute myeloid leukemia (AML). It includes attributes such as age at diagnosis, gender, prior malignancy history, treatment details (chemotherapy, radiation), genetic mutations (FLT3-ITD, NPM1), cytogenetic findings (FAB classification, karyotype), and RNA sequencing data. The dataset also incorporates information on relapse, transformation, and vital status, alongside details on specimen acquisition and diagnosis. The data is used for defining global filters to limit browsing and for comparing sample groups within a larger analysis.
vizome.org
IP: 45.60.106.143
加载中...
相关论文
5Super-enhancer-associated long noncoding RNA lnc-SPI1U mediates SPI1 feedback regulation by interacting with HNRNPH1 and HNRNPF
Xuefei Ma•Yilu Li•Weifen Sun•Jiacheng Lou•Yi Zhang等 8 人
Oncogene
2025
•2025/10/24
•00 p.1-13
Long noncoding RNAs (lncRNAs) have been extensively studied for their regulatory roles in gene expression; however, relatively little is known about those specifically associated with super-enhancers (SEs)—genomic elements crucial for maintaining cell identity and function. This study profiles acute...
Acute myeloid leukaemiaNon-coding RNAs
10.1038/S41388-025-03612-9
ISSN:0950-9232
Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity
Haojie Dong•Xin He•Lei Zhang•Wei Chen•Yi-Chun Lin等 32 人
Nature Cancer
2024
•2024/2/27
•00 p.1-24
Current anticancer therapies cannot eliminate all cancer cells, which hijack normal arginine methylation as a means to promote their maintenance via unknown mechanisms. Here we show that targeting protein arginine N-methyltransferase 9 (PRMT9), whose activities are elevated in blasts and leukemia st...
CancerTumour immunology
10.1038/S43018-024-00736-X
ISSN:2662-1347
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics
Xin He•Lei Zhang•Yang Li•Song-Bai Liu•Zheng Li等 33 人
Nature Cancer
2026
•2026/6/26
•Vol.7 No.6 p.944-963
De novo purine synthesis is required to maintain tumor growth; however, its impact on therapy resistance remains unclear. Here, through a dynamic BH3-priming-based CRISPR screen, we found that deletion of ADSS2, which encodes the adenylosuccinate synthase 2 enzyme essential for adenosine monophospha...
Acute myeloid leukaemiaCancerCancer therapeutic resistanceTargeted therapies
10.1038/S43018-026-01184-5
ISSN:2662-1347
Integrated transcriptomic and genomic analysis improves prediction of complete remission and survival in elderly patients with acute myeloid leukemia
Albin Österroos•My Björklund•Anna Eriksson•Johan Lindberg•Christer Nilsson等 9 人
Blood Cancer Journal
2020
•2020/6/11
•Vol.10 No.6 p.1-10
Relevant molecular tools for treatment stratification of patients ≥65 years with acute myeloid leukemia (AML) are lacking. We combined clinical data with targeted DNA- and full RNA-sequencing of 182 intensively and palliatively treated patients to predict complete remission (CR) and survival in AML ...
Acute myeloid leukaemiaCancer geneticsGenetics research
10.1038/S41408-020-0332-3
ISSN:2044-5385
Bipartite network models to design combination therapies in acute myeloid leukaemia
Jafari Mohieddin•Mirzaie Mehdi•Bao Jie•Barneh Farnaz•Zheng Shuyu等 8 人
Nature Communications
2022
•2022/4/19
•Vol.13 No.1 p.1-12
Combination therapy is preferred over single-targeted monotherapies for cancer treatment due to its efficiency and safety. However, identifying effective drug combinations costs time and resources. We propose a method for identifying potential drug combinations by bipartite network modelling of pati...
Computational modelsHaematological cancerSystems biology
10.1038/S41467-022-29793-5
ISSN:2041-1723